Investigates hypoxia's impact on scleral remodeling in guinea pig models, suggesting new therapeutic targets.
BACKGROUND: The progression of myopia is typically accompanied by hypoxia-induced remodeling of the scleral extracellular matrix (ECM). In this study, we focused on the regulatory mechanisms underlying Notch signaling pathway activation of mitochondrial dynamics under conditions of scleral hypoxia, along with its effects on the scleral ECM. METHODS: Three-week-old male guinea pigs were used to establish form-deprived myopia (FDM) models, and human scleral fibroblasts (HSFs) were cultured in a hypoxic environment. To examine the intrinsic associations among factors, we used short hairpin RNAs (shRNAs) to independently knock down hypoxia-inducible factor alpha (HIF-1α) and Notch1. Expression of key molecules was assessed by western blotting, quantitative real-time polymerase chain reaction (qPCR), and immunofluorescence (IF) analyses. Additionally, mitochondrial morphology, membrane potential (ΔΨm), and reactive oxygen species (ROS) levels were assessed, and the specific dynamin-related protein 1 (DRP1) inhibitor Mdivi-1 was used to determine its regulatory effects on scleral ECM. RESULTS: . CONCLUSION: , inhibition of mitochondrial fission appeared to mitigate the transformation of human scleral fibroblasts toward a myofibroblast-like phenotype. These findings provide evidence of a novel hypoxia-associated cellular pathway that warrants further investigation to establish its causal role and therapeutic relevance in myopic scleral remodeling.
No takes yet. Share an insight, caveat, or question.
Ba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: